Trials / Completed
CompletedNCT00851578
ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to characterize the performance of the WATCHMAN LAA Closure Device in atrial fibrillation patients for which long term warfarin therapy is contraindicated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | WATCHMAN | WATCHMAN LAA Closure Device |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2012-02-01
- Completion
- 2013-12-01
- First posted
- 2009-02-26
- Last updated
- 2015-01-27
Locations
4 sites across 2 countries: Czechia, Germany
Source: ClinicalTrials.gov record NCT00851578. Inclusion in this directory is not an endorsement.